应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
CDTX Cidara Therapeutics, Inc.
已收盘 11-22 16:00:00 EST
20.40
+2.95
+16.91%
盘后
21.99
+1.59
+7.79%
19:05 EST
最高
21.28
最低
17.52
成交量
25.58万
今开
17.73
昨收
17.45
日振幅
21.57%
总市值
1.44亿
流通市值
7,171万
总股本
704.66万
成交额
506.95万
换手率
7.28%
流通股本
351.51万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Cidara Therapeutics, Inc.盘中异动 股价大涨7.79%
市场透视 · 11-22 22:31
Cidara Therapeutics, Inc.盘中异动 股价大涨7.79%
BUZZ--美国股票走势-爵士制药公司、SPAR、Alphabet
Reuters · 11-22 00:01
BUZZ--美国股票走势-爵士制药公司、SPAR、Alphabet
BUZZ-Cidara Therapeutics 募资 1.05 亿美元,业绩大幅增长
路透中文 · 11-21 23:28
BUZZ-Cidara Therapeutics 募资 1.05 亿美元,业绩大幅增长
Cidara Therapeutics, Inc.盘中异动 快速拉升6.12%报14.75美元
市场透视 · 11-15
Cidara Therapeutics, Inc.盘中异动 快速拉升6.12%报14.75美元
Cidara Therapeutics Inc 预计每股亏损4.25美元 - 财报前瞻
Reuters · 10-29
Cidara Therapeutics Inc 预计每股亏损4.25美元 - 财报前瞻
Cidara Therapeutics, Inc.盘中异动 早盘股价大涨5.11%报11.73美元
市场透视 · 10-25
Cidara Therapeutics, Inc.盘中异动 早盘股价大涨5.11%报11.73美元
Cidara Therapeutics, Inc.盘中异动 早盘大幅跳水7.00%报10.37美元
市场透视 · 10-18
Cidara Therapeutics, Inc.盘中异动 早盘大幅跳水7.00%报10.37美元
Cidara Therapeutics, Inc.盘中异动 早盘大幅拉升5.93%
自选股智能写手 · 08-14
Cidara Therapeutics, Inc.盘中异动 早盘大幅拉升5.93%
Cidara Therapeutics, Inc.盘中异动 快速拉升5.71%
自选股智能写手 · 08-14
Cidara Therapeutics, Inc.盘中异动 快速拉升5.71%
Cidara Therapeutics, Inc.盘中异动 大幅下挫6.57%
自选股智能写手 · 08-05
Cidara Therapeutics, Inc.盘中异动 大幅下挫6.57%
Cidara Therapeutics Inc 预计每股亏损4.10美元 - 财报前瞻
Reuters · 07-30
Cidara Therapeutics Inc 预计每股亏损4.10美元 - 财报前瞻
Cidara Therapeutics, Inc.盘中异动 股价大涨6.69%报12.75美元
自选股智能写手 · 07-26
Cidara Therapeutics, Inc.盘中异动 股价大涨6.69%报12.75美元
Cidara Therapeutics, Inc.盘中异动 早盘大幅跳水6.98%
自选股智能写手 · 07-02
Cidara Therapeutics, Inc.盘中异动 早盘大幅跳水6.98%
Cidara Therapeutics, Inc.盘中异动 快速上涨5.53%报13.55美元
自选股智能写手 · 06-11
Cidara Therapeutics, Inc.盘中异动 快速上涨5.53%报13.55美元
Cidara Therapeutics, Inc.盘中异动 早盘大幅上涨5.52%
自选股智能写手 · 06-06
Cidara Therapeutics, Inc.盘中异动 早盘大幅上涨5.52%
Cidara Therapeutics, Inc.盘中异动 急速下挫6.81%
自选股智能写手 · 06-05
Cidara Therapeutics, Inc.盘中异动 急速下挫6.81%
Cidara Therapeutics, Inc.盘中异动 早盘股价大涨5.67%报12.49美元
自选股智能写手 · 05-30
Cidara Therapeutics, Inc.盘中异动 早盘股价大涨5.67%报12.49美元
加载更多
公司概况
公司名称:
Cidara Therapeutics, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Cidara Therapeutics, Inc.原本以K2 Therapeutics公司的名字于2012年12月在特拉华州注册成立,2014年7月更名为Cidara Therapeutics公司。公司是一家生物技术公司,专注于发现,开发和商业化新的抗感染剂用于治疗疾病是由护理疗法目前标准充分解决。 CD101是棘白菌素类,一类成熟的抗真菌剂。该公司最初的专有候选产品是其新化合物,CD101,对于严重的真菌感染的治疗配方。该公司的第一个产品是候补CD101静脉内,以前biafungin,一个潜在的每周一次静脉内,或IV,治疗被用于全身性真菌感染的治疗和预防的发展。该公司的第二个候选产品,CD101外用,原名topifungin,是一种外用制剂CD101用于治疗外阴阴道念珠菌病,或VVC,一个普遍的粘膜感染。 CD101局部是棘白菌素类抗真菌剂中的所述第一局部施用。此外,该公司已开发出专有的免疫治疗技术平台,CloudbreakTM,它用它来创建,旨在引导患者的免疫细胞来攻击和消灭病原体引起的感染性疾病的化合物。该公司正在开发其第一个断云开发的候选人,C001,用于治疗侵袭性曲霉病,引起真菌病原体,曲霉菌感染。公司正在评估更多的机会来扩大其断云免疫平台,传染病等领域。
发行价格:
--
{"stockData":{"symbol":"CDTX","market":"US","secType":"STK","nameCN":"Cidara Therapeutics, Inc.","latestPrice":20.4,"timestamp":1732309200000,"preClose":17.45,"halted":0,"volume":255755,"hourTrading":{"tag":"盘后","latestPrice":21.99,"preClose":20.4,"latestTime":"19:05 EST","volume":36645,"amount":736411.94,"timestamp":1732320313198},"delay":0,"floatShares":3515132,"shares":7046633,"eps":-23.940947,"marketStatus":"已收盘","marketStatusCode":5,"change":2.95,"latestTime":"11-22 16:00:00 EST","open":17.73,"high":21.284,"low":17.52,"amount":5069485.07273,"amplitude":0.215702,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-23.940947,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1732525200000},"adr":0,"listingDate":1429070400000,"adjPreClose":17.45,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":17.4,"preClose":17.45,"latestTime":"09:17 EST","volume":1091,"amount":19516.501876000002,"timestamp":1732285029552},"postHourTrading":{"tag":"盘后","latestPrice":21.99,"preClose":20.4,"latestTime":"19:05 EST","volume":36645,"amount":736411.94,"timestamp":1732320313198},"volumeRatio":2.161626,"impliedVol":3.3875,"impliedVolPercentile":0.514},"requestUrl":"/m/hq/s/CDTX","defaultTab":"news","newsList":[{"id":"2485426156","title":"Cidara Therapeutics, Inc.盘中异动 股价大涨7.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485426156","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485426156?lang=zh_cn&edition=full","pubTime":"2024-11-22 22:31","pubTimestamp":1732285861,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日22时31分,Cidara Therapeutics, Inc.股票出现异动,股价急速上涨7.79%。Cidara Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.37%。其相关个股中,Exicure, Inc.、Virpax Pharmaceuticals, Inc.、Replimune Group, Inc.涨幅较大,Virpax Pharmaceuticals, Inc.、Molecular Templates, Inc.、Exicure, Inc.较为活跃,换手率分别为489.68%、60.62%、31.08%,振幅较大的相关个股有Kairos Pharma, Ltd.、Io Biotech, Inc.、Citius Pharmaceuticals, Inc.,振幅分别为9.19%、7.04%、5.39%。Cidara Therapeutics, Inc.公司简介:Cidara Therapeutics Inc 正在开发免疫治疗,旨在帮助提高面临重病的患者的治疗标准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112222310198e4426b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112222310198e4426b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CDTX","BK4139"],"gpt_icon":0},{"id":"2485419860","title":"BUZZ--美国股票走势-爵士制药公司、SPAR、Alphabet","url":"https://stock-news.laohu8.com/highlight/detail?id=2485419860","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485419860?lang=zh_cn&edition=full","pubTime":"2024-11-22 00:01","pubTimestamp":1732204914,"startTime":"0","endTime":"0","summary":"** BJ's Wholesale Club Holdings Inc : BUZZ - 在上调年度预期后跳涨 ** Aptiv PLC : BUZZ - Guggenheim下调了Aptiv的PT,原因是2025年利润率预期较低。** Cameco Corp : BUZZ - 在加拿大皇家银行资本市场上调预期后上涨 ** Ulta Beauty Inc : BUZZ - 下跌,因William Blair下调评级,原因是品类疲软和在线风险。** Adient PLC : BUZZ - 因报告称美国银行下调评级、下调预测价值而下跌。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DE","DDM","ADNT","NEM","JAZZ","SNOW","WMG","BJ",".DJI","NVD2.UK","DFH","NVDU","APTV","CNX","3NVD.UK","NVDS.UK","QLD","ULTA","KURA","NQmain","ROAD","FMNB","SQQQ","TEX","CDTX","DOG","NVDY","2NVD.UK","NVDS",".IXIC",".SPX","CTRA","DTM","APA","GOOGL","EQT","IGIC","NVDA","PSQ","QID","NVD3.UK","SDOW","MNQmain","SNVD.UK","JACK","GOOG"],"gpt_icon":1},{"id":"2485413079","title":"BUZZ-Cidara Therapeutics 募资 1.05 亿美元,业绩大幅增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2485413079","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485413079?lang=zh_cn&edition=full","pubTime":"2024-11-21 23:28","pubTimestamp":1732202881,"startTime":"0","endTime":"0","summary":"11月21日 - ** 制药商 Cidara Therapeutics 的 CDTX.O 股价上涨 20.9% 至 18.28 美元 ** CDTX 在私募中融资 1.05 亿美元 ,公司称 ** 公司称,Venrock Healthcare Capital Partners和其他专注于生命科学的投资者将以每股14.912美元的价格购买约390万股CDTX股票。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241121:nL4T3MS19D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CDTX","BK4139"],"gpt_icon":0},{"id":"2483033163","title":"Cidara Therapeutics, Inc.盘中异动 快速拉升6.12%报14.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483033163","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483033163?lang=zh_cn&edition=full","pubTime":"2024-11-15 04:16","pubTimestamp":1731615386,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日04时16分,Cidara Therapeutics, Inc.股票出现波动,股价急速上涨6.12%。Cidara Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为1.35%。其相关个股中,60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Molecular Templates, Inc.涨幅较大,Molecular Templates, Inc.、Elevai Labs, Inc.、Pulmatrix, Inc.较为活跃,换手率分别为4790.58%、3432.46%、397.09%,振幅较大的相关个股有Molecular Templates, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 ,振幅分别为249.67%、218.18%、188.46%。Cidara Therapeutics, Inc.公司简介:Cidara Therapeutics Inc 正在开发免疫治疗,旨在帮助提高面临重病的患者的治疗标准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111504162798e42b97&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111504162798e42b97&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CDTX","BK4139","LENZ"],"gpt_icon":0},{"id":"2479039470","title":"Cidara Therapeutics Inc 预计每股亏损4.25美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2479039470","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479039470?lang=zh_cn&edition=full","pubTime":"2024-10-29 19:17","pubTimestamp":1730200664,"startTime":"0","endTime":"0","summary":" * Cidara Therapeutics Inc 预计将在10月31日公布截至2024年9月30日的业绩(预计),季度收入将出现下降。* 根据LSEG的数据,3位分析师的平均预期显示,这家总部位于加利福尼亚州圣地亚哥的公司的营收预计将从去年同期的1272万美元下降96.6%,至43.33万美元。* LSEG 分析师对 Cidara Therapeutics Inc 的平均预期是每股亏损 4.25 美元。* 华尔街对 Cidara Therapeutics Inc 的 12 个月目标价中位数为 25.00 美元,高于其最新收盘价 12.47 美元。10月29日 - 上一季度业绩。除非另有说明,所有数字均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CDTX","LENZ"],"gpt_icon":0},{"id":"2478789935","title":"Cidara Therapeutics, Inc.盘中异动 早盘股价大涨5.11%报11.73美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478789935","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478789935?lang=zh_cn&edition=full","pubTime":"2024-10-25 21:59","pubTimestamp":1729864740,"startTime":"0","endTime":"0","summary":"北京时间2024年10月25日21时59分,Cidara Therapeutics, Inc.股票出现异动,股价快速拉升5.11%。截至发稿,该股报11.73美元/股,成交量4321股,换手率0.06%,振幅2.20%。Cidara Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.60%。Cidara Therapeutics, Inc.公司简介:Cidara Therapeutics Inc 正在开发免疫治疗,旨在帮助提高面临重病的患者的治疗标准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102521590198e3e82a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102521590198e3e82a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","CDTX"],"gpt_icon":0},{"id":"2476325561","title":"Cidara Therapeutics, Inc.盘中异动 早盘大幅跳水7.00%报10.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2476325561","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476325561?lang=zh_cn&edition=full","pubTime":"2024-10-18 21:53","pubTimestamp":1729259583,"startTime":"0","endTime":"0","summary":"北京时间2024年10月18日21时53分,Cidara Therapeutics, Inc.股票出现波动,股价大幅下跌7.00%。Cidara Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.28%。其相关个股中,Bright Minds Biosciences Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Cingulate Inc C/Wts 10/12/2026 涨幅较大,Bright Minds Biosciences Inc.、Salarius Pharmaceuticals, Inc.、Windtree Therapeutics, Inc.较为活跃,换手率分别为137.51%、124.78%、55.71%,振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Klotho Neurosciences Inc C/Wts 21/06/2029 、Bright Minds Biosciences Inc.,振幅分别为119.64%、66.29%、28.80%。Cidara Therapeutics, Inc.公司简介:Cidara Therapeutics Inc 正在开发免疫治疗,旨在帮助提高面临重病的患者的治疗标准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410182153039f4d9348&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410182153039f4d9348&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","CDTX"],"gpt_icon":0},{"id":"2459970105","title":"Cidara Therapeutics, Inc.盘中异动 早盘大幅拉升5.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459970105","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459970105?lang=zh_cn&edition=full","pubTime":"2024-08-14 23:03","pubTimestamp":1723647797,"startTime":"0","endTime":"0","summary":"北京时间2024年08月14日23时03分,Cidara Therapeutics, Inc.股票出现异动,股价快速拉升5.93%。Cidara Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.30%。其相关个股中,Zura Bio Limited C/Wts 、Newamsterdam Pharma Co Nv C/Wts 、Revolution Medicines Inc C/Wts 17/12/2026 涨幅较大,Genprex, Inc.、Conduit Pharmaceuticals Inc.、Tc Biopharm Plc较为活跃,换手率分别为86.05%、72.23%、65.47%,振幅较大的相关个股有Seastar Medical Holding Corp C/Wts 28/10/2027 、Genprex, Inc.、Tc Biopharm Plc,振幅分别为60.83%、58.52%、49.86%。Cidara Therapeutics, Inc.公司简介:Cidara Therapeutics Inc 正在开发免疫治疗,旨在帮助提高面临重病的患者的治疗标准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240814230317aefec10b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240814230317aefec10b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CDTX","LENZ","BK4139"],"gpt_icon":0},{"id":"2459318481","title":"Cidara Therapeutics, Inc.盘中异动 快速拉升5.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459318481","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459318481?lang=zh_cn&edition=full","pubTime":"2024-08-14 03:38","pubTimestamp":1723577931,"startTime":"0","endTime":"0","summary":"北京时间2024年08月14日03时38分,Cidara Therapeutics, Inc.股票出现波动,股价急速拉升5.71%。Cidara Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为2.17%。其相关个股中,Cardio Diagnostics Holdings Inc C/Wts To Pur Com、Apollomics Inc C/Wts 01/04/2028 、Prelude Therapeutics Incorporated涨幅较大,Genprex, Inc.、冠科美博、Oragenics Inc.较为活跃,换手率分别为152.30%、141.04%、42.67%,振幅较大的相关个股有冠科美博、Zura Bio Limited C/Wts 、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 ,振幅分别为83.32%、59.26%、57.86%。Cidara Therapeutics, Inc.公司简介:Cidara Therapeutics Inc 正在开发免疫治疗,旨在帮助提高面临重病的患者的治疗标准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240814033851968260d7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240814033851968260d7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CDTX","BK4139","LENZ"],"gpt_icon":0},{"id":"2457775653","title":"Cidara Therapeutics, Inc.盘中异动 大幅下挫6.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457775653","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457775653?lang=zh_cn&edition=full","pubTime":"2024-08-05 21:38","pubTimestamp":1722865100,"startTime":"0","endTime":"0","summary":"北京时间2024年08月05日21时38分,Cidara Therapeutics, Inc.股票出现波动,股价急速下跌6.57%。Cidara Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为1.94%。其相关个股中,Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Zevra Therapeutics, Inc.、Oculis Holding Ag C/Wts 06/03/2028 涨幅较大,Cns Pharmaceuticals, Inc.、Dermata Therapeutics, Inc.、Senti Biosciences, Inc.较为活跃,换手率分别为1068.31%、51.70%、14.09%,振幅较大的相关个股有Alterity Therapeutics Limited、Cns Pharmaceuticals, Inc.、60 Degrees Pharmaceuticals, Inc.,振幅分别为20.00%、19.99%、17.59%。Cidara Therapeutics, Inc.公司简介:Cidara Therapeutics Inc 正在开发免疫治疗,旨在帮助提高面临重病的患者的治疗标准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805213820957f322b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805213820957f322b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CDTX","LENZ"],"gpt_icon":0},{"id":"2455515959","title":"Cidara Therapeutics Inc 预计每股亏损4.10美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2455515959","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455515959?lang=zh_cn&edition=full","pubTime":"2024-07-30 22:56","pubTimestamp":1722351383,"startTime":"0","endTime":"0","summary":" * Cidara Therapeutics Inc 预计将在8月1日公布截至2024年6月30日的业绩报告时显示季度收入下降(预计) * 根据LSEG的数据,2位分析师的平均预期显示,这家总部位于加利福尼亚州圣地亚哥的公司的营收预计将从去年同期的761万美元下降38.3%,至470万美元。* LSEG 分析师对 Cidara Therapeutics Inc 的平均预期是每股亏损 4.10 美元。* 华尔街对 Cidara Therapeutics Inc 的 12 个月目标价中位数为 40.00 美元,高于其最后收盘价 13.05 美元。7月30日 - 本摘要于北京时间 7 月 30 日 14:56 机器生成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CDTX","LENZ"],"gpt_icon":0},{"id":"2454910321","title":"Cidara Therapeutics, Inc.盘中异动 股价大涨6.69%报12.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2454910321","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454910321?lang=zh_cn&edition=full","pubTime":"2024-07-26 22:58","pubTimestamp":1722005890,"startTime":"0","endTime":"0","summary":"北京时间2024年07月26日22时58分,Cidara Therapeutics, Inc.股票出现异动,股价大幅上涨6.69%。Cidara Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.41%。其相关个股中,Estrella Immunopharma Inc C/Wts 29/09/2028、Windtree Therapeutics, Inc.、Celularity Inc C/Wts 16/07/2026 涨幅较大,Windtree Therapeutics, Inc.、Novabay Pharmaceuticals, Inc.、Salarius Pharmaceuticals, Inc.较为活跃,换手率分别为5155.13%、170.85%、97.64%,振幅较大的相关个股有Windtree Therapeutics, Inc.、Sangamo Therapeutics, Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028,振幅分别为86.32%、66.22%、57.50%。Cidara Therapeutics, Inc.公司简介:Cidara Therapeutics Inc 正在开发免疫治疗,旨在帮助提高面临重病的患者的治疗标准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240726225810aefbb3e6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240726225810aefbb3e6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CDTX","LENZ"],"gpt_icon":0},{"id":"2448615246","title":"Cidara Therapeutics, Inc.盘中异动 早盘大幅跳水6.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2448615246","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448615246?lang=zh_cn&edition=full","pubTime":"2024-07-02 21:37","pubTimestamp":1719927464,"startTime":"0","endTime":"0","summary":"北京时间2024年07月02日21时37分,Cidara Therapeutics, Inc.股票出现波动,股价大幅跳水6.98%。Cidara Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.81%。其相关个股中,Anew Medical, Inc.、Passage Bio, Inc.、阿诺医药涨幅较大,Gri Bio, Inc.、Geovax Labs, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃,换手率分别为36.97%、12.54%、7.40%,振幅较大的相关个股有Gri Bio, Inc.、Qualigen Therapeutics, Inc.、Sensei Biotherapeutics, Inc.,振幅分别为21.05%、17.46%、16.79%。Cidara Therapeutics, Inc.公司简介:Cidara Therapeutics Inc 正在开发免疫治疗,旨在帮助提高面临重病的患者的治疗标准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024070221374496818d1c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024070221374496818d1c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CDTX","BK4139"],"gpt_icon":0},{"id":"2442487526","title":"Cidara Therapeutics, Inc.盘中异动 快速上涨5.53%报13.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2442487526","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2442487526?lang=zh_cn&edition=full","pubTime":"2024-06-11 04:00","pubTimestamp":1718049649,"startTime":"0","endTime":"0","summary":"北京时间2024年06月11日04时00分,Cidara Therapeutics, Inc.股票出现异动,股价快速上涨5.53%。Cidara Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.11%。其相关个股中,Surrozen Inc C/Wts 01/08/2031 、Artelo Biosciences Inc C/Wts 20/06/2024 、Clene Inc C/Wts 30/12/2025 涨幅较大,Cns Pharmaceuticals, Inc.、Calidi Biotherapeutics, Inc.、Hoth Therapeutics, Inc.较为活跃,换手率分别为70.26%、46.76%、43.38%,振幅较大的相关个股有Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Seastar Medical Holding Corp C/Wts 28/10/2027 、Dermata Therapeutics Inc C/Wts ,振幅分别为142.25%、134.12%、108.54%。Cidara Therapeutics, Inc.公司简介:Cidara Therapeutics Inc 是一家生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240611040049aef42e2f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240611040049aef42e2f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CDTX","BK4139","LENZ"],"gpt_icon":0},{"id":"2441103597","title":"Cidara Therapeutics, Inc.盘中异动 早盘大幅上涨5.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2441103597","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2441103597?lang=zh_cn&edition=full","pubTime":"2024-06-06 21:32","pubTimestamp":1717680759,"startTime":"0","endTime":"0","summary":"北京时间2024年06月06日21时32分,Cidara Therapeutics, Inc.股票出现异动,股价快速拉升5.52%。截至发稿,该股报13.19美元/股,成交量3108股,换手率0.07%,振幅2.32%。Cidara Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.10%。其相关个股中,Virax Biolabs Group Limited、Vanda Pharmaceuticals Inc.、Dyadic International, Inc.涨幅较大,Virax Biolabs Group Limited、Geovax Labs, Inc.、Lixte Biotechnology Holdings, Inc.较为活跃,换手率分别为1319.58%、73.32%、11.53%,振幅较大的相关个股有Engene Holdings Inc C/Wts 31/10/2028 Cl A、Virax Biolabs Group Limited、Dyadic International, Inc.,振幅分别为54.74%、22.41%、10.65%。Cidara Therapeutics, Inc.公司简介:Cidara Therapeutics Inc 是一家生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240606213240aef3d132&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240606213240aef3d132&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CDTX","BK4139","LENZ"],"gpt_icon":0},{"id":"2441127138","title":"Cidara Therapeutics, Inc.盘中异动 急速下挫6.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2441127138","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2441127138?lang=zh_cn&edition=full","pubTime":"2024-06-05 21:41","pubTimestamp":1717594862,"startTime":"0","endTime":"0","summary":"北京时间2024年06月05日21时41分,Cidara Therapeutics, Inc.股票出现异动,股价急速下挫6.81%。截至发稿,该股报11.50美元/股,成交量902股,换手率0.02%,振幅6.81%。Cidara Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.33%。其相关个股中,Psyence Biomedical Ltd C/Wts 25/01/2029、Vir Biotechnology, Inc.、Eliem Therapeutics, Inc涨幅较大,Adial Pharmaceuticals, Inc、Cns Pharmaceuticals, Inc.、Mustang Bio, Inc.较为活跃,换手率分别为43.66%、13.11%、5.97%,振幅较大的相关个股有Silo Pharma, Inc.、Maia Biotechnology, Inc.、Adial Pharmaceuticals, Inc,振幅分别为23.56%、19.57%、13.97%。Cidara Therapeutics, Inc.公司简介:Cidara Therapeutics Inc 是一家生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406052141029f1cf20e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406052141029f1cf20e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CDTX","BK4139","LENZ"],"gpt_icon":0},{"id":"2439626191","title":"Cidara Therapeutics, Inc.盘中异动 早盘股价大涨5.67%报12.49美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2439626191","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2439626191?lang=zh_cn&edition=full","pubTime":"2024-05-30 23:00","pubTimestamp":1717081251,"startTime":"0","endTime":"0","summary":"北京时间2024年05月30日23时00分,Cidara Therapeutics, Inc.股票出现异动,股价大幅拉升5.67%。截至发稿,该股报12.49美元/股,成交量4543股,换手率0.10%,振幅2.20%。Cidara Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.28%。其相关个股中,Nkgen Biotech Inc C/Wts 31/05/2028、Ocean Biomedical Inc C/Wts 14/02/2028 、Humacyte Inc C/Wts 27/08/2026 涨幅较大,Kintara Therapeutics, Inc.、Mustang Bio, Inc.、Onconetix, Inc.较为活跃,换手率分别为93.44%、57.67%、55.92%,振幅较大的相关个股有Calidi Biotherapeutics, Inc.、Ocean Biomedical Inc C/Wts 14/02/2028 、Kintara Therapeutics, Inc.,振幅分别为93.84%、73.83%、51.32%。Cidara Therapeutics, Inc.公司简介:Cidara Therapeutics Inc 是一家生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240530230051af8b2ba5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240530230051af8b2ba5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CDTX","LENZ","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cidara.com","stockEarnings":[{"period":"1week","weight":0.2051},{"period":"1month","weight":0.5334},{"period":"3month","weight":0.3444},{"period":"6month","weight":0.4517},{"period":"1year","weight":0.2203},{"period":"ytd","weight":0.0989}],"compareEarnings":[{"period":"1week","weight":0.0005},{"period":"1month","weight":0.0177},{"period":"3month","weight":0.0561},{"period":"6month","weight":0.1213},{"period":"1year","weight":0.3047},{"period":"ytd","weight":0.249}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Cidara Therapeutics, Inc.原本以K2 Therapeutics公司的名字于2012年12月在特拉华州注册成立,2014年7月更名为Cidara Therapeutics公司。公司是一家生物技术公司,专注于发现,开发和商业化新的抗感染剂用于治疗疾病是由护理疗法目前标准充分解决。 CD101是棘白菌素类,一类成熟的抗真菌剂。该公司最初的专有候选产品是其新化合物,CD101,对于严重的真菌感染的治疗配方。该公司的第一个产品是候补CD101静脉内,以前biafungin,一个潜在的每周一次静脉内,或IV,治疗被用于全身性真菌感染的治疗和预防的发展。该公司的第二个候选产品,CD101外用,原名topifungin,是一种外用制剂CD101用于治疗外阴阴道念珠菌病,或VVC,一个普遍的粘膜感染。 CD101局部是棘白菌素类抗真菌剂中的所述第一局部施用。此外,该公司已开发出专有的免疫治疗技术平台,CloudbreakTM,它用它来创建,旨在引导患者的免疫细胞来攻击和消灭病原体引起的感染性疾病的化合物。该公司正在开发其第一个断云开发的候选人,C001,用于治疗侵袭性曲霉病,引起真菌病原体,曲霉菌感染。公司正在评估更多的机会来扩大其断云免疫平台,传染病等领域。","yearOnYearQuotes":[{"month":1,"riseRate":0.444444,"avgChangeRate":0.011897},{"month":2,"riseRate":0.222222,"avgChangeRate":-0.058092},{"month":3,"riseRate":0.555556,"avgChangeRate":0.024396},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.08466},{"month":5,"riseRate":0.5,"avgChangeRate":-0.003901},{"month":6,"riseRate":0.4,"avgChangeRate":-0.014011},{"month":7,"riseRate":0.3,"avgChangeRate":0.006371},{"month":8,"riseRate":0.4,"avgChangeRate":0.011706},{"month":9,"riseRate":0.4,"avgChangeRate":0.017964},{"month":10,"riseRate":0.3,"avgChangeRate":-0.053421},{"month":11,"riseRate":0.6,"avgChangeRate":0.039975},{"month":12,"riseRate":0.444444,"avgChangeRate":0.02901}],"exchange":"NASDAQ","name":"Cidara Therapeutics, Inc.","nameEN":"Cidara Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Cidara Therapeutics, Inc.(CDTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Cidara Therapeutics, Inc.(CDTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Cidara Therapeutics, Inc.,CDTX,Cidara Therapeutics, Inc.股票,Cidara Therapeutics, Inc.股票老虎,Cidara Therapeutics, Inc.股票老虎国际,Cidara Therapeutics, Inc.行情,Cidara Therapeutics, Inc.股票行情,Cidara Therapeutics, Inc.股价,Cidara Therapeutics, Inc.股市,Cidara Therapeutics, Inc.股票价格,Cidara Therapeutics, Inc.股票交易,Cidara Therapeutics, Inc.股票购买,Cidara Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Cidara Therapeutics, Inc.(CDTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Cidara Therapeutics, Inc.(CDTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}